Diagnosis And Differential Diagnosis Of Bachmann-Bupp Syndrome
Published on: April 14, 2025
Diagnosis and differential diagnosis of Bachmann-Bupp syndrome featured image
Article reviewer photo

AJ Goldman

MBBS, St George’s Hospital Medical School

Introduction

Bachmann-Bupp Syndrome (BABS) is a rare genetic disorder caused by mutations in the ODC1 gene. These changes lead to a buildup of the enzyme ornithine decarboxylase (ODC) in cells, resulting in a range of symptoms.

Key Characteristics:

  • Alopecia: BABS features a distinctive type of hair loss
  • Developmental Delay: Individuals experience moderate to severe global developmental delays
  • Hypotonia: Reduced muscle tone is a common symptom
  • Dysmorphic Features: The syndrome includes nonspecific physical abnormalities
  • Behavioral Issues: These can include autism spectrum disorder and attention-deficit/hyperactivity disorder (ADHD)
  • Feeding Difficulties: Problems with feeding are often observed
  • Genetic Basis: Mutations in the ODC1 Gene: BABS is caused by gain-of-function mutations in this gene. These mutations result in truncated forms of the ODC enzyme
  • Enzyme Accumulation: The truncation prevents normal degradation of the enzyme, leading to its buildup in cells, where it remains active and affects normal cellular functions
  • Neurodevelopmental Disorder: BABS is primarily a neurodevelopmental disorder marked by developmental delays and hypotonia

Non-Congenital Alopecia: The condition also includes varying forms of non-congenital hair loss.
Understanding BABS is crucial for early diagnosis and management, which helps provide better care and support for those affected.1,2,3

This article aims to give a clear and detailed guide for diagnosing Bachmann-Bupp Syndrome (BABS) and distinguishing it from similar conditions. By recognizing the specific symptoms and genetic basis of BABS, healthcare providers can make accurate diagnoses and offer the right care. This guide will highlight key features like developmental delays, low muscle tone (hypotonia), and hair loss (alopecia) and outline the steps and tests needed for a thorough evaluation. It also emphasizes the importance of differentiating BABS from other disorders with similar symptoms to ensure patients get the correct diagnosis and treatment.

Common Symptoms

  • Hair Loss: Notable loss of hair within the first few weeks of life, including absent or sparse eyebrows and eyelashes
  • Dysmorphic Features: Presence of nonspecific physical abnormalities
  • Developmental Delays: Significant delays in motor and speech development, with walking typically achieved between 17 months and 4 years
  • Hypotonia: Reduced muscle tone is a common symptom
  • Macrocephaly: An unusually large head size, defined as an occipitofrontal circumference (OFC) greater than the 97th percentile for age and sex
  • Macrosomia: Large body size in early infancy, with weight and length exceeding the 95th percentile for age and sex
  • Recurrent Follicular Cysts: Frequent development of small cysts in hair follicles

Onset and Duration

  • Prenatal History: Many affected individuals have a history of polyhydramnios, an excessive accumulation of amniotic fluid during pregnancy
  • Early Symptoms: The characteristic alopecia and developmental delays typically become apparent shortly after birth and persist into early childhood

Patient History

  • Thorough Medical History: A comprehensive medical history is crucial for identifying prenatal conditions like polyhydramnios and early life symptoms such as alopecia and developmental delays
  • Family History: Investigating any family history of similar symptoms can provide additional context and aid in the diagnostic process4,5

Diagnostic Criteria

Physical Examination

Alopecia

  • Initial Hair Condition: Hair present at birth, sometimes sparse or of an atypical color (either darker or lighter than expected)
  • Early Hair Loss: Noticeable loss of hair within the first few weeks of life
  • Eyebrows: Absent or sparse eyebrows

Dysmorphic Features

  • Non-Specific: Presence of nonspecific physical abnormalities.

Developmental Delays

  • Motor Delays: Delay in achieving motor milestones; walking typically occurs between 17 months and 4 years
  • Speech Delays: First words are usually spoken between 3 and 6 years

Hypotonia

  • Muscle Tone: Reduced muscle tone, contributing to motor developmental delays.

Behavioral Characteristics

  • ADHD and Autism: Behavioral issues including ADHD and autism spectrum disorder
  • Aggressive Tendencies: Presence of aggressive behavior

Growth Patterns

  • Macrocephaly: Larger than average head circumference for age and sex
  • Macrosomia: Larger body size at birth, although this often resolves with age5

Molecular Genetic Testing

Molecular genetic testing is the most effective method for accurately diagnosing Bachmann-Bupp Syndrome (BABS). Depending on the patient's symptoms, two main types of testing can be employed:

Gene-Targeted Testing

  • Purpose: To detect small intragenic deletions, insertions, and specific missense, nonsense, and splice site variants in the ODC1 gene
  • Method: Sequencing of the ODC1 gene to identify specific pathogenic variants

Comprehensive Genomic Testing

A diagnosis of BABS is made based on identifying characteristic symptoms and confirming the presence of a pathogenic variant in the ODC1 gene. Currently, there are no established consensus clinical diagnostic criteria for BABS.

Laboratory Tests

Additional tests may be conducted to evaluate specific symptoms associated with BABS:

Electroencephalogram (EEG)

  • Purpose: Recommended if there is evidence or suspicion of seizure activity, such as body shaking or staring spells
  • Function: Measures electrical activity in the brain, helping to detect and analyse seizure patterns

Brain MRI

  • Purpose: Several BABS patients have shown changes on brain MRIs
  • Findings: No recurrent pattern of abnormalities has been established, but MRI can help identify and monitor brain function

These tests, in conjunction with molecular genetic testing, provide a comprehensive clinical workup to accurately diagnose and understand Bachmann-Bupp Syndrome.3

Differential Diagnosis

CHD3

  • Disorder: Snijders Blok-Campeau syndrome (SNIBCPS; OMIM 618205)
  • Mode of Inheritance: Autosomal Dominant (AD)
  • Shared Features with BABS:
    • Developmental Delay (DD)
    • Large head size (macrocephaly)
    • Low muscle tone (hypotonia)
  • Distinctive Features:
    • Enlarged brain ventricles (ventriculomegaly)
    • Common dysmorphic features
    • Joint laxity

DCAF17

  • Disorder: Woodhouse-Sakati syndrome (OMIM 241080)
  • Mode of Inheritance: Autosomal Recessive (AR)
  • Shared Features with BABS:
    • Complete hair loss (alopecia totalis)
    • Involuntary muscle contractions (dystonia)
  • Distinctive Features:
    • Underdeveloped sex organs (hypogonadism)
    • Diabetes mellitus

LSS

  • Disorder: LSS-related neurodevelopmental disorder (OMIM 618840)
  • Mode of Inheritance: Autosomal Recessive (AR)
  • Shared Features with BABS:
    • Hair loss (alopecia)
    • Developmental Delay (DD)
    • Seizures (epilepsy)
  • Distinctive Features:
    • Hair loss is present from birth (congenital alopecia)

PAK1

  • Disorder: Intellectual developmental disorder with macrocephaly, seizures, and speech delay (IDDMSSD; OMIM 618158)
  • Mode of Inheritance: Autosomal Dominant (AD)
  • Shared Features with BABS:
    • Developmental Delay (DD)
    • Large head size (macrocephaly)
    • Seizures
  • Distinctive Features:
    • Lack of coordination (ataxia)
    • No consistent hair and skin abnormalities

PTEN

  • Disorder: Cowden syndrome (part of PTEN Hamartoma Tumor Syndrome)
  • Mode of Inheritance: Autosomal Dominant (AD)
  • Shared Features with BABS:
    • Developmental Delay (DD)
    • Large head size (macrocephaly)
  • Distinctive Features:
    • Facial skin growths (trichilemmomas)
    • Skin lesions on the extremities (acral keratoses)
    • Small, wart-like growths (papillomatous papules)
    • Increased risk for breast, thyroid, and endometrial cancers4

Diagnostic Approach

Growth Measurement

Evaluate growth parameters to check for overgrowth in infancy and childhood.

Evaluation by Gastroenterology/Nutrition Team

  • Assess for aspiration risk, nutritional status, and signs of constipation
  • Special feeding techniques may be needed, such as using a special nipple or nasogastric tube in infancy
  • Consider gastric tube placement for those with swallowing difficulties or aspiration risk

Developmental Assessment

  • Include evaluations for motor skills, adaptive behavior, cognitive abilities, and speech/language development
  • Assess the need for early intervention or special education

Neuropsychiatric Evaluation

For children over 12 months, screen for behavioral concerns like ADHD, aggression, and autism spectrum disorder traits.

Neurologic Evaluation

Consider an EEG and brain MRI if seizures are suspected.

Ophthalmologic Evaluation

Check for eye alignment and refractive errors.

Audiology Evaluation

Assess for hearing loss and determine its type.

Physical Exam for Follicular Cysts

Consider a referral to a dermatologist.

Heart Examination

Listen for heart murmurs and consider an echocardiogram if needed.

Genetic Counseling

Inform patients and families about the nature, mode of inheritance, and implications of BABS to assist with medical and personal decision-making.

Family Support and Resources

Determine the use of community or online resources such as Parent to Parent.

  • Assess the need for social work involvement for parental support
  • Consider a referral for home nursing if needed2

Challenges in Diagnosis

Rarity of the Condition

BABS is very rare, so many doctors may not know about it, causing delays in diagnosis.

Similar Symptoms with Other Disorders

Symptoms like developmental delays and hair loss are common in many disorders, making it hard to pinpoint BABS without genetic testing.

Non-specific Symptoms

Symptoms such as developmental delays, low muscle tone, and unusual facial features are seen in many conditions, which can lead to misdiagnosis.

Access to Genetic Testing

Not all patients can easily access the specific genetic tests needed to diagnose BABS due to costs and availability.

Variable Symptoms

The severity and type of symptoms can vary widely among individuals with BABS, making it hard to recognize the syndrome consistently.

Lack of Awareness

Because BABS is so rare, both doctors and the general public may not know much about it, leading to fewer diagnoses.

Need for Multiple Specialists

Diagnosing BABS often requires different types of doctors, such as neurologists and geneticists, which can be difficult to coordinate.

No Standard Diagnostic Criteria

There are no set guidelines for diagnosing BABS, making it harder for doctors to identify it based on symptoms alone.

Early Symptoms

Some symptoms appear very early in life, before more specific signs like hair loss, which can delay diagnosis.

Psychiatric and Behavioral Symptoms

Conditions like ADHD and autism, which are common in BABS, can mask the underlying genetic cause and delay proper diagnosis.6

Summary

Bachmann-Bupp Syndrome (BABS) is a rare genetic disorder caused by mutations in the ODC1 gene, leading to the buildup of the enzyme ornithine decarboxylase in cells. This results in a range of symptoms, including distinctive hair loss (alopecia), significant developmental delays, reduced muscle tone (hypotonia), nonspecific physical abnormalities, and behavioral issues such as autism and ADHD.

Patients often face feeding difficulties and may have an unusually large head size (macrocephaly) and body size (macrosomia) in early infancy. Diagnosing BABS can be tough because it’s so rare and shares symptoms with other conditions, requiring specialised genetic tests. However, early understanding and diagnosis of BABS can make a big difference, helping families get the right care and support they need.

References

  1. Bachmann AS, VanSickle EA, Michael J, Vipond M, Bupp CP. Bachmann-Bupp syndrome and treatment. Dev Med Child Neurol. 2024; 66(4):445–55.
  2. Bupp C, Michael J, VanSickle E, Rajasekaran S, Bachmann AS. Bachmann-Bupp Syndrome. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJ, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993 [cited 2024 Aug 6]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK583220/.
  3. Bachmann-Bupp Syndrome - Symptoms, Causes, Treatment | NORD [Internet]. [cited 2024 Aug 6]. Available from: https://rarediseases.org/rare-diseases/bachmann-bupp-syndrome/.
  4. Bupp C, Michael J, VanSickle E, et al. Bachmann-Bupp Syndrome. 2022 Aug 25. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK583220/
  5. Wikipedia [Internet]. 2024. Bachmann-Bupp syndrome [cited 2024 Aug 6]. Available from: https://en.wikipedia.org/w/index.php?title=Bachmann-Bupp_syndrome&oldid=1219131213.
  6. Afrin A, Afshan TS, VanSickle EA, Michael J, Laarman RL, Bupp CP. Improvement of dermatological symptoms in patients with Bachmann–Bupp syndrome using difluoromethylornithine treatment. Pediatric Dermatology [Internet]. 2023 [cited 2024 Aug 6]; 40(3):528–31. Available from: https://onlinelibrary.wiley.com/doi/10.1111/pde.15187.
Share

Kareeza Selby Chacko

arrow-right